WhitTier Trust Company’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$738K Sell
7,077
-1,685
-19% -$150K 0.01% 348
2026
Q1
$642K Sell
8,762
-1,431
-14% -$110K 0.01% 350
2025
Q4
$823K Sell
10,193
-59
-0.6% -$4.65K 0.02% 309
2025
Q3
$794K Sell
10,252
-2,339
-19% -$160K 0.02% 305
2025
Q2
$868K Sell
12,591
-1,324
-10% -$86.8K 0.02% 325
2025
Q1
$943K Sell
13,915
-1,227
-8% -$73.4K 0.02% 312
2024
Q4
$680K Sell
15,142
-563
-4% -$31.6K 0.02% 327
2024
Q3
$988K Sell
15,705
-2,221
-12% -$130K 0.03% 295
2024
Q2
$1.06M Sell
17,926
-52,928
-75% -$3.31M 0.03% 277
2024
Q1
$5.65M Buy
70,854
+604
+0.9% +$46.1K 0.16% 127
2023
Q4
$5.55M Buy
70,250
+1,138
+2% +$81K 0.18% 120
2023
Q3
$4.82M Sell
69,112
-1,261
-2% -$89.3K 0.17% 127
2023
Q2
$4.86M Sell
70,373
-1,096
-2% -$78K 0.16% 127
2023
Q1
$5.31M Buy
71,469
+952
+1% +$79.8K 0.2% 118
2022
Q4
$6.57M Buy
70,517
+283
+0.4% +$27.3K 0.26% 94
2022
Q3
$6.7M Buy
70,234
+2,092
+3% +$207K 0.29% 80
2022
Q2
$6.31M Buy
68,142
+3,784
+6% +$369K 0.26% 93
2022
Q1
$6.51M Buy
64,358
+6,094
+10% +$640K 0.24% 105
2021
Q4
$6.01M Buy
58,264
+2,269
+4% +$210K 0.22% 109
2021
Q3
$4.75M Buy
55,995
+959
+2% +$80.3K 0.19% 117
2021
Q2
$4.59M Sell
55,036
-989
-2% -$81K 0.19% 120
2021
Q1
$4.21M Buy
56,025
+5,551
+11% +$404K 0.19% 118
2020
Q4
$3.45M Sell
50,474
-498
-1% -$32.4K 0.17% 123
2020
Q3
$2.98M Sell
50,972
-42
-0.1% -$2.61K 0.17% 121
2020
Q2
$3.31M Sell
51,014
-1,051
-2% -$66.2K 0.21% 107
2020
Q1
$3.09M Buy
52,065
+2,899
+6% +$194K 0.24% 98
2019
Q4
$3.65M Buy
49,166
+2,186
+5% +$153K 0.23% 102
2019
Q3
$2.96M Sell
46,980
-1,011
-2% -$59.9K 0.21% 107
2019
Q2
$2.62M Sell
47,991
-5,014
-9% -$270K 0.19% 114
2019
Q1
$2.86M Sell
53,005
-7,922
-13% -$489K 0.21% 108
2018
Q4
$3.99M Buy
60,927
+5,195
+9% +$388K 0.33% 78
2018
Q3
$4.39M Sell
55,732
-3,065
-5% -$219K 0.32% 83
2018
Q2
$3.78M Sell
58,797
-202
-0.3% -$13.3K 0.3% 88
2018
Q1
$3.67M Buy
58,999
+5,450
+10% +$391K 0.3% 88
2017
Q4
$3.88M Sell
53,549
-10,500
-16% -$763K 0.33% 81
2017
Q3
$5.21M Buy
64,049
+933
+1% +$73.8K 0.48% 59
2017
Q2
$5.08M Buy
63,116
+1,145
+2% +$90.4K 0.49% 61
2017
Q1
$4.86M Buy
61,971
+6,685
+12% +$534K 0.49% 61
2016
Q4
$4.36M Sell
55,286
-159
-0.3% -$12.9K 0.46% 66
2016
Q3
$4.93M Buy
55,445
+1,848
+3% +$174K 0.56% 54
2016
Q2
$5.13M Buy
53,597
+1,252
+2% +$125K 0.59% 53
2016
Q1
$5.43M Buy
52,345
+930
+2% +$90.4K 0.63% 49
2015
Q4
$5.03M Buy
51,415
+2,606
+5% +$255K 0.59% 52
2015
Q3
$4.71M Buy
48,809
+1,589
+3% +$167K 0.58% 54
2015
Q2
$4.95M Buy
47,220
+1,248
+3% +$128K 0.55% 58
2015
Q1
$4.74M Sell
45,972
-165
-0.4% -$16.7K 0.53% 64
2014
Q4
$4.44M Sell
46,137
-43
-0.1% -$3.79K 0.5% 63
2014
Q3
$3.68M Buy
46,180
+788
+2% +$62.1K 0.42% 70
2014
Q2
$3.42M Buy
45,392
+1,993
+5% +$151K 0.38% 74
2014
Q1
$3.25M Buy
43,399
+1,357
+3% +$95.9K 0.38% 74
2013
Q4
$3.01M Buy
42,042
+4,681
+13% +$301K 0.36% 79
2013
Q3
$2.12M Buy
37,361
+2,584
+7% +$154K 0.28% 86
2013
Q2
$1.99M Buy
+34,777
New +$2.01M 0.29% 85

Other funds holding CVS

WhitTier Trust Company's CVS Position: Q2 2026 in Review

WhitTier Trust Company reduced its CVS Health (CVS) stake by 19% in Q2 2026, selling an estimated $150K and leaving 7,077 shares worth $738K. The position accounts for 0.01% of the portfolio, ranked #348.

WhitTier Trust Company first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.7M in Q3 2022. 886 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • WhitTier Trust Company held 7,077 shares of CVS Health worth $738K as of Q2 2026.
  • WhitTier Trust Company sold 1,685 CVS Health shares in Q2 2026, an estimated $150K.
  • CVS Health made up 0.01% of WhitTier Trust Company's portfolio in Q2 2026, its #348 holding.
  • WhitTier Trust Company first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • WhitTier Trust Company's CVS Health position peaked at $6.7M in Q3 2022.
  • 886 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on WhitTier Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.